[Long term treatment of a parkinsonism with l-dopa].
D000284:Administration, Oral; D001264:Athetosis / Q000139:chemically induced; D002819:Chorea / Q000139:chemically induced; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009325:Nausea / Q000139:chemically induced; D010300:Parkinson Disease / Q000188:drug therapy*; D013997:Time Factors; D014839:Vomiting / Q000139:chemically induced
D004295:Dihydroxyphenylalanine
Langtidsbehandling av parkinsonisme med l-dopa.